loader image

January 2023 Banner
COVID19 UPDATES
FDA UPDATES
EUA UPDATES
Slide
Slide
Slide 1
Learn More
IEC
MORE
previous arrow
next arrow

Featured Activity

Featured Activity || The Food and Drug Administration (FDA) recently had a meeting with the President, His Excellency Ferdinand Marcos, Jr., and the Private Sector Advisory Council (PSAC) to discuss ways to enhance the country’s healthcare sector.

By Administrator 3  / March 30, 2023
Manila, Philippines - The Food and Drug Administration (FDA) recently had a meeting with the President, His Excellency Ferdinand Marcos,...
Read More
Featured Activity || The Food and Drug Administration (FDA) recently had a meeting with the President, His Excellency Ferdinand Marcos, Jr., and the Private Sector Advisory Council (PSAC) to discuss ways to enhance the country’s healthcare sector.

Featured Activity || The Food and Drug Administration is with the nation in celebrating the 2023 National Women’s Month with the theme “WE for Gender Equality and Inclusive Society”

By Administrator 3  / March 10, 2023
TRIVIA TIME! Do you know that International Women’s Day is celebrated every 8th of March? It began in New York...
Read More
Featured Activity || The Food and Drug Administration is with the nation in celebrating the 2023 National Women’s Month with the theme “WE for Gender Equality and Inclusive Society”

Featured Activity || Food and Drug Administration Director General (DG) Dr. Samuel A. Zacate met the Center for Drug Regulation and Research (CDRR) employees for an open forum.

By Administrator 3  / February 8, 2023
Food and Drug Administration Director General (DG) Dr. Samuel A. Zacate met the Center for Drug Regulation and Research (CDRR)...
Read More
Featured Activity || Food and Drug Administration Director General (DG) Dr. Samuel A. Zacate met the Center for Drug Regulation and Research (CDRR) employees for an open forum.

Featured Activity || On 16 December 2022, the Food and Drug Administration (FDA) conducted a Licensing Seminar held at the Bohol Tropics, Tagbilaran City, Bohol.

By Administrator 3  / December 28, 2022
On 16 December 2022, the Food and Drug Administration (FDA) conducted a Licensing Seminar held at the Bohol Tropics, Tagbilaran...
Read More
Featured Activity || On 16 December 2022, the Food and Drug Administration (FDA) conducted a Licensing Seminar held at the Bohol Tropics, Tagbilaran City, Bohol.

Featured Activity || 18th NBW (DOH – FDA Healthcare Forum on Biotechnology)

By Administrator 3  / December 1, 2022
On 21 – 25 November 2022, the annual celebration of the 18th National Biotechnology Week (NBW) pursuant to Proclamation No....
Read More
Featured Activity || 18th NBW (DOH – FDA Healthcare Forum on Biotechnology)

Featured Activity || Anti-Red Tape Authority (ARTA) “Streamlining and Digitalization of Government Processes in the Health Sector During and Beyond the Pandemic”

By Administrator 3  / November 24, 2022
The Food and Drug Administration (FDA) participated in the health forum conducted by the Anti-Red Tape Authority (ARTA) with the...
Read More
Featured Activity || Anti-Red Tape Authority (ARTA) “Streamlining and Digitalization of Government Processes in the Health Sector During and Beyond the Pandemic”

Featured Activity || Philippine Antimicrobial Awareness Week

By Administrator 3  / November 24, 2022
The Food and Drug Administration (FDA) participated in the Philippine Antimicrobial Awareness Week 2002 last Tuesday, November 22 at Seda...
Read More
Featured Activity || Philippine Antimicrobial Awareness Week

Featured Activity || The Food and Drug Administration (FDA) in Central Luzon, NBI NCR, and NBI Bulacan District Office seized counterfeit products worth P300 million in a recent raid on nine (9) establishments in Bulacan.

By Administrator 3  / November 2, 2022
The Food and Drug Administration (FDA) in Central Luzon, NBI NCR, and NBI Bulacan District Office seized counterfeit products worth...
Read More
Featured Activity || The Food and Drug Administration (FDA) in Central Luzon, NBI NCR, and NBI Bulacan District Office seized counterfeit products worth P300 million in a recent raid on nine (9) establishments in Bulacan.

Featured Activity || The Food and Drug Administration (FDA) participated in the Better Regulations Summit 2022 held by the Anti-Red Tape Authority (ARTA) last Friday, October 7 at the Philippine International Convention Center.

By Administrator 3  / October 12, 2022
The Food and Drug Administration (FDA) participated in the Better Regulations Summit 2022 held by the Anti-Red Tape Authority (ARTA)...
Read More
Featured Activity || The Food and Drug Administration (FDA) participated in the Better Regulations Summit 2022 held by the Anti-Red Tape Authority (ARTA) last Friday, October 7 at the Philippine International Convention Center.

Featured Activity || The Food and Drug Administration (FDA) participated in the three-day International Food Exhibition (IFEX) Philippines 2022 held last September 22 to 24 at the World Trade Center Metro Manila in Pasay City.

By Administrator 3  / October 3, 2022
The Food and Drug Administration (FDA) participated in the three-day International Food Exhibition (IFEX) Philippines 2022 held last September 22...
Read More
Featured Activity || The Food and Drug Administration (FDA) participated in the three-day International Food Exhibition (IFEX) Philippines 2022 held last September 22 to 24 at the World Trade Center Metro Manila in Pasay City.
View More

Featured Event

Play
Play
Play
Play
Previous
Next

Featured Video

Play
Play
Play
Play
Play
Play
Previous
Next

Our Services

For Products and Establishments registration at FDA

Verification Portal

Check the List of Approved FDA
Authorizations

Go to Verification Portal

eServices Portal

New Online Application System for FDA Authorizations

Go to eServices

ePortal System

Apply and Register for License to Operate, Certificate of Product Registration, and other FDA Authorizations

Go to ePortal

ePortal v.2 System

Authorizations for HUHS and Novel Tobacco Products

Go to ePortal v.2

RRDportal

Applications for Licensing and Registration of Radiation Facilities and Other Related Authorizations

Go to RRDportal

COVID19-related Updates

(Click Logo below for Updates)

Latest Advisories

FDA Advisory No.2023-0492 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Supplement “Serpentina King of Bitters”

FDA Advisory No.2023-0492 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Supplement “Serpentina King of Bitters”

By Administrator 2  / March 27, 2023
The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND CONSUME  the...
Read More
FDA Advisory No.2023-0491 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Product “COFFEELICIOUS Rice Coffee with Lagundi”

FDA Advisory No.2023-0491 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Product “COFFEELICIOUS Rice Coffee with Lagundi”

By Administrator 2  / March 27, 2023
The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND CONSUME the...
Read More
FDA Advisory No.2023-0490 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Product “UNBRANDED Brown Rice Coffee”

FDA Advisory No.2023-0490 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Product “UNBRANDED Brown Rice Coffee”

By Administrator 2  / March 27, 2023
The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND CONSUME  the...
Read More
FDA Advisory No.2023-0489 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Product “FAITH NATURE FARM Sambong 3 in 1 Herbal Tea with Mint and Stevia”

FDA Advisory No.2023-0489 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Product “FAITH NATURE FARM Sambong 3 in 1 Herbal Tea with Mint and Stevia”

By Administrator 2  / March 27, 2023
The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND CONSUME the...
Read More
FDA Advisory No.2023-0488 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Supplement “SUPER NUTRITION Tawa-Tawa Euphorbia hirta Herbal Supplement”

FDA Advisory No.2023-0488 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Supplement “SUPER NUTRITION Tawa-Tawa Euphorbia hirta Herbal Supplement”

By Administrator 2  / March 27, 2023
The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND CONSUME the unregistered...
Read More
FDA Advisory No.2023-0487 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Supplement “UNBRANDED Reishi MushroomGanoderma Herbal Capsules”

FDA Advisory No.2023-0487 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Supplement “UNBRANDED Reishi MushroomGanoderma Herbal Capsules”

By Administrator 2  / March 27, 2023
The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND CONSUME  the...
Read More
FDA Advisory No.2023-0486 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Supplement “EDHAWA HEALTH & WELLNESS GKUB Flush Food Supplement”

FDA Advisory No.2023-0486 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Supplement “EDHAWA HEALTH & WELLNESS GKUB Flush Food Supplement”

By Administrator 2  / March 27, 2023
The Food and Drug Administration (FDA) warns all healthcare professionals and the general public  NOT TO PURCHASE AND CONSUME  the...
Read More
FDA Advisory No.2023-0485 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Supplement “RLB ORGANICS Paragis”

FDA Advisory No.2023-0485 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Supplement “RLB ORGANICS Paragis”

By Administrator 2  / March 27, 2023
The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND CONSUME the...
Read More
FDA Advisory No.2023-0484 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Supplement “UNBRANDED Japan Algae Spirulina Extract Herbal Food Supplement”

FDA Advisory No.2023-0484 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Supplement “UNBRANDED Japan Algae Spirulina Extract Herbal Food Supplement”

By Administrator 2  / March 27, 2023
The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND CONSUME the...
Read More
FDA Advisory No.2023-0507 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Product “MG FETALINO FOOD PRODUCTS Banana Strips”

FDA Advisory No.2023-0507 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Product “MG FETALINO FOOD PRODUCTS Banana Strips”

By Administrator 3  / March 27, 2023
The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND CONSUME the...
Read More
View More

Announcement

Announcement || Notification Letter: Taiwan Intends to Import Eggs for Human Consumption from the Philippines
Please be advised that the Food and Drug Administration received a notification letter from the Taipei Economic and Cultural Office ...
Read More
Announcement || ASEAN Joint Assessment Procedure
Under the auspices of the ASEAN Consultative Committee for Standards and Quality – Pharmaceutical Product Working Group (ACCSQ-PPWG), and with ...
Read More
Introduction to Pharmaceutical Product Registration (IPPR)
The program aims to provide an introduction and procedural discussion on the regulatory requirements of pharmaceutical products for human use ...
Read More

FDA on the News

FDA on the News || What’s inside the Food and Drug Administration? Watch and know more about FDA under its new leadership, Director General Samuel A. Zacate

FDA on the News || What’s inside the Food and Drug Administration? Watch and know more about FDA under its new leadership, Director General Samuel A. Zacate

By Administrator 3  / November 26, 2022
Alam niyo ba na halos lahat ng kinokonsumo ng tao ay kailangan dumaan sa masusing pagsusuri ng Food and Drug...
Read More
FDA on the News || Giyera kontra counterfeit items, idineklara ng FDA Chief

FDA on the News || Giyera kontra counterfeit items, idineklara ng FDA Chief

By Administrator 3  / November 19, 2022
Nagdeklara ang Food and Drug Administration ng war agaisnt counterfeit medicines. Ang pahayag ng FDA kasabay ng pagdiriwang ng National...
Read More
FDA on the News || Pinangungunahan ng Food and Drug Administration (FDA) ang pagdiriwang ng ‘National Consciousness Week Against Counterfeit Medicine.’

FDA on the News || Pinangungunahan ng Food and Drug Administration (FDA) ang pagdiriwang ng ‘National Consciousness Week Against Counterfeit Medicine.’

By Administrator 3  / November 18, 2022
TINGNAN | Pinangungunahan ng Food and Drug Administration (FDA) ang pagdiriwang ng 'National Consciousness Week Against Counterfeit Medicine.' Kasalukuyang ginaganap...
Read More
FDA on the News || Food and Drug Administration (FDA) Harmonies graced the program In the Heart of Business by DWIZ 882 last Friday, November 11.

FDA on the News || Food and Drug Administration (FDA) Harmonies graced the program In the Heart of Business by DWIZ 882 last Friday, November 11.

By Administrator 3  / November 15, 2022
They performed their renditions of True Colors by Cyndi Lauper and "Pekeng Gamot," which was composed by Mr. Jonathan Sta....
Read More
PH FDA QUALIFIES AS 5th ASEAN INSPECTION SERVICE

PH FDA QUALIFIES AS 5th ASEAN INSPECTION SERVICE

By Administrator  / May 15, 2019
PH FDA QUALIFIES AS 5th ASEAN LISTED INSPECTION SERVICE - The Philippine Food and Drug Administration (FDA) has successfully qualified...
Read More
FDA Chief Orders Clean-Up Of Backlog

FDA Chief Orders Clean-Up Of Backlog

By Administrator  / July 15, 2018
The Food and Drug Administration (FDA) is set to take drastic moves to address the backlog in the processing of...
Read More
FDA chief bats for early cancer detection

FDA chief bats for early cancer detection

By Administrator  / May 27, 2018
Food and Drug Administration (FDA) Director-General Nela Charade G. Puno last week called on women to have regular breast examinations,...
Read More
View More

Press Statements

Press Statement || 21 February 2023 FDA Philippines Launches Task Force Fleming to Make Safe and Effective Covid-19 Drugs More Accessible to All Filipinos.

Press Statement || 21 February 2023 FDA Philippines Launches Task Force Fleming to Make Safe and Effective Covid-19 Drugs More Accessible to All Filipinos.

By Administrator 3  / February 21, 2023
The Philippine Food and Drug Administration (FDA), an attached agency of the Department of Health (DOH), launched Taskforce Fleming, a...
Read More
Press Release || The Food and Drug Administration (FDA), in partnership with the Local Government Units (LGUs), launches the Bigyang-halaga, Bangon MSMEs (Micro, Small, and Medium Enterprises) Program.

Press Release || The Food and Drug Administration (FDA), in partnership with the Local Government Units (LGUs), launches the Bigyang-halaga, Bangon MSMEs (Micro, Small, and Medium Enterprises) Program.

By Administrator 3  / January 13, 2023
The Food and Drug Administration (FDA), in partnership with the Local Government Units (LGUs), launches the Bigyang-halaga, Bangon MSMEs (Micro,...
Read More
FDA Press Statement || Updates on the Voluntary Recall of Sangobion Kids Syrup

FDA Press Statement || Updates on the Voluntary Recall of Sangobion Kids Syrup

By Administrator 3  / January 13, 2023
The Food and Drug Administration (FDA) issued FDA Advisory No. 2022-1968 on the voluntary recall of Iron + Vitamin B...
Read More
FDA STATEMENT || On Diethylene glycol and Ethylene glycol – contaminated Cough and Cold Syrup Manufactured by Maiden Pharmaceuticals, Ltd.

FDA STATEMENT || On Diethylene glycol and Ethylene glycol – contaminated Cough and Cold Syrup Manufactured by Maiden Pharmaceuticals, Ltd.

By Administrator 3  / October 28, 2022
All pharmaceutical products, especially cough and cold syrups, that use glycerine as solvent, diluent, and thickening agent, are mandatorily required...
Read More
Press Statement || The Food and Drug Administration (FDA) Launches Taskforce Edward Which Aims to Make Safe and Effective COVID-19 Vaccines More Accessible to All Filipinos

Press Statement || The Food and Drug Administration (FDA) Launches Taskforce Edward Which Aims to Make Safe and Effective COVID-19 Vaccines More Accessible to All Filipinos

By Administrator 3  / August 16, 2022
Food and Drug Administration (FDA) Director General Dr. Samuel Zacate launches Taskforce Edward which has the primary objective to make...
Read More
Press Statement || The Food and Drug Administration (FDA) joins the Department of Health (DOH) in requesting the Presidential veto of Senate Bill No. 2239 and House Bill No. 9007, or the Vape Bill. The FDA strongly echoes the sentiments of the DOH that the Vape Bill is not a health bill.

Press Statement || The Food and Drug Administration (FDA) joins the Department of Health (DOH) in requesting the Presidential veto of Senate Bill No. 2239 and House Bill No. 9007, or the Vape Bill. The FDA strongly echoes the sentiments of the DOH that the Vape Bill is not a health bill.

By Administrator 2  / July 21, 2022
The Food and Drug Administration (FDA) joins the Department of Health (DOH) in requesting the Presidential veto of Senate Bill...
Read More
FDA STATEMENT || ACTIONS RELATIVE TO THE EU-RASFF ALERT ON LUCKY ME! INSTANT NOODLE PRODUCTS MANUFACTURED IN THAILAND

FDA STATEMENT || ACTIONS RELATIVE TO THE EU-RASFF ALERT ON LUCKY ME! INSTANT NOODLE PRODUCTS MANUFACTURED IN THAILAND

By Administrator 2  / July 11, 2022
The FDA received a copy of the European Union Rapid Alert System for Food and Feed (EU-RASFF) that Lucky Me!...
Read More
Press Release || FDA lauds SC decision upholding the agency’s regulatory authority over tobacco products 23 June 2022

Press Release || FDA lauds SC decision upholding the agency’s regulatory authority over tobacco products 23 June 2022

By Administrator 2  / June 24, 2022
The Food and Drug Administration (FDA) lauds the Supreme Court decision upholding the agency’s jurisdiction over tobacco products reaffirming the...
Read More
Press Statement || FDA Philippines Grants Emergency Use Authorization of CoronaVac (Sinovac) for Pediatric Group

Press Statement || FDA Philippines Grants Emergency Use Authorization of CoronaVac (Sinovac) for Pediatric Group

By Administrator 2  / March 15, 2022
On 11 March 2022, the Food and Drug Administration (FDA) granted the Emergency Use Authorization (EUA) of CoronaVac Vaccine, manufactured...
Read More
Press Release || FDA APPROVES SELF-ADMINISTERED COVID-19 ANTIGEN TEST KITS

Press Release || FDA APPROVES SELF-ADMINISTERED COVID-19 ANTIGEN TEST KITS

By Administrator 2  / January 25, 2022
The Food and Drug Administration (FDA) has approved two (2) self-administered COVID-19 antigen test kits in compliance with the application...
Read More
View More
Transparency-Seal

FOI

ISO

Citizens-Charter

GAD

Verification-Logo

Pharmacovigilance

Pharmacovigilance

Draft for Comments

Draft for Comments || Rules and Guidelines on the Issuance of Import Permit as “Samples Only” for FDA Regulated Products Intended for Research and Development Purposes

By Administrator 2  / March 30, 2023
All concerns stakeholders may submit comments in MSWord format via email to [email protected] with copy furnish to [email protected] on before...
Read More
Draft for Comments || Rules and Guidelines on the Issuance of Import Permit as “Samples Only” for FDA Regulated Products Intended for Research and Development Purposes

Draft for Comments || Request for Inputs on the 5th Draft of the ASEAN Pharmaceutical Regulatory Framework (APRF) Agreement

By Administrator 2  / March 29, 2023
The Policy and Planning Service (PPS) respectfully informs the pharmaceutical stakeholders of the posting of the 5th Draft of the...
Read More
Draft for Comments || Request for Inputs on the 5th Draft of the ASEAN Pharmaceutical Regulatory Framework (APRF) Agreement

Draft for Comments || Guidelines on Food and Drug Administration’s Regulatory Responses During Declared National or State of Public Health Emergencies

By Administrator 2  / January 31, 2023
All comments may be sent at [email protected] The deadline for submission of comments is on 15 February 2023. I. RATIONALE In upholding...
Read More
Draft for Comments || Guidelines on Food and Drug Administration’s Regulatory Responses During Declared National or State of Public Health Emergencies

Draft for Comments || Updated Guidelines for Availing Compassionate Special Permit for the Restricted Use of Unregistered or Unauthorized Drug Products including Vaccines and Medical Devices

By Administrator 2  / January 26, 2023
All comments may be sent at [email protected] The deadline for submission of comments is on 09 February 2023. I. BACKGROUND...
Read More
Draft for Comments || Updated Guidelines for Availing Compassionate Special Permit for the Restricted Use of Unregistered or Unauthorized Drug Products including Vaccines and Medical Devices

Draft for Comments || Addendum to Administrative Order No. 50 s. 2001 entitled “Revised 2001 Schedule of fees and Charges for the Corresponding Services Rendered by the Bureau of Food and Drugs.”

By Administrator 3  / January 26, 2023
All comments may be sent at [email protected] The deadline for submission of comments is on 09 February 2023. I. RATIONALE On...
Read More
Draft for Comments || Addendum to Administrative Order No. 50 s. 2001 entitled “Revised 2001 Schedule of fees and Charges for the Corresponding Services Rendered by the Bureau of Food and Drugs.”

Draft for Comments || Revised Guidelines on Food Additives and Processing Aids, Repealing Administrative Order 88-A s. 1984

By Administrator 2  / January 19, 2023
You may submit your comments in MSWord format to [email protected] The deadline for submission of comments is on 03 February 2023. Draft for...
Read More
Draft for Comments || Revised Guidelines on Food Additives and Processing Aids, Repealing Administrative Order 88-A s. 1984

Draft for Comments || Guidelines on the Adoption of 2015 Philippine Dietary Reference Intakes (PDRI) for Declaration of Nutrition Information on the Labels Repealing Bureau Circular No. 16 s. 2005 entitled “Adopting the 2002 Recommended Energy and Nutrient Intakes as the New Dietary Standard”

By Administrator 2  / January 18, 2023
You may submit your comments in MSWord format to [email protected] The deadline for submission of comments is on 02 February 2023. Draft for...
Read More
Draft for Comments || Guidelines on the Adoption of 2015 Philippine Dietary Reference Intakes (PDRI) for Declaration of Nutrition Information on the Labels Repealing Bureau Circular No. 16 s. 2005 entitled “Adopting the 2002 Recommended Energy and Nutrient Intakes as the New Dietary Standard”

Draft for Comments || Guidelines Prescribing the Principle of Reliance for Regulatory Decisions of the Food and Drug Administration

By Administrator 2  / November 25, 2022
All comments may be sent at [email protected] with the following Subject format: a. Comments_AO on Reliance for Regulatory Decision
Read More
Draft for Comments || Guidelines Prescribing the Principle of Reliance for Regulatory Decisions of the Food and Drug Administration

Draft for Comments || Guidelines on Food and Drug Administration’s Regulatory Responses During Declared National Public Health Emergencies

By Administrator 2  / November 25, 2022
All comments may be sent at [email protected] with the following Subject format: a. Comments_AO on National Public Health Emergencies
Read More
Draft for Comments || Guidelines on Food and Drug Administration’s Regulatory Responses During Declared National Public Health Emergencies

Draft for Comments || Guidelines on Ethylene Oxide Residue Level in Raw Materials and Processed Prepackaged Food

By Administrator 3  / November 22, 2022
You may submit your comments in MSWord format to [email protected] Cc [email protected] on or before 08 December 2022 using the...
Read More
Draft for Comments || Guidelines on Ethylene Oxide Residue Level in Raw Materials and Processed Prepackaged Food
View More

Bids and Awards

ITB No. 2023-0034-ICTMD || Procurement of One (1) Year Subscription of Cloud Infrastructure Service

By Administrator 2  / March 28, 2023
Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of One (1) Year Subscription of Cloud Infrastructure Service Bidding Documents    ...
Read More
ITB No. 2023-0034-ICTMD || Procurement of One (1) Year Subscription of Cloud Infrastructure Service

NP-RFP-2023-0005-IMS || Procurement of a Certifying Body to the 1st Surveillance Audit for ISO 9001:2015 Quality Management System “QMS” of Food and Drug Administration

By Administrator 3  / February 9, 2023
Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of a Certifying Body to the 1st Surveillance Audit for ISO 9001:2015 Quality...
Read More
NP-RFP-2023-0005-IMS || Procurement of a Certifying Body to the 1st Surveillance Audit for ISO 9001:2015 Quality Management System “QMS” of Food and Drug Administration

NP-SVP(A)-2023-0003-AFS || Procurement of the Construction Materials for the Renovation / Rehabilitation of FDA Annex Building Basement for Storage of Unserviceable/Condemned Office Equipment/Records file for Safekeeping

By Administrator 2  / January 26, 2023
Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of the Construction Materials for the Renovation / Rehabilitation of FDA Annex Building...
Read More
NP-SVP(A)-2023-0003-AFS || Procurement of the Construction Materials for the Renovation / Rehabilitation of FDA Annex Building Basement for Storage of Unserviceable/Condemned Office Equipment/Records file for Safekeeping

NP-SVP(A)-2022-0257-SLC || Procurement of Smart TV and Stand (Mobile)

By Administrator 2  / December 23, 2022
Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of Smart TV and Stand (Mobile)        
Read More
NP-SVP(A)-2022-0257-SLC || Procurement of Smart TV and Stand (Mobile)

NP-SVP(A)-2022-0258-ICTMD || Procurement for the Repair / Retermination and Testing of FDA Fiber Optic Cable Located at CDRR

By Administrator 2  / December 22, 2022
Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement for the Repair / Retermination and Testing of FDA Fiber Optic Cable Located...
Read More
NP-SVP(A)-2022-0258-ICTMD || Procurement for the Repair / Retermination and Testing of FDA Fiber Optic Cable Located at CDRR

NP-SVP(A)-2022-0256-AFS || Procurement of Memorabilia / Souvenir Items as Loyalty Incentives

By Administrator 2  / December 21, 2022
Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of Memorabilia / Souvenir Items as Loyalty Incentives Technical Specification    
Read More
NP-SVP(A)-2022-0256-AFS || Procurement of Memorabilia / Souvenir Items as Loyalty Incentives

ITB No. 2022-0250-FROO-EPA || Procurement of One (1) Year Security Services for FDA Regional Field Offices and Warehouses, Cebu Testing and Quality Assurance Laboratory (CTQAL), and Davao Testing Quality Assurance Laboratory (DTQAL)

By Administrator 3  / December 20, 2022
Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of One (1) Year Security Services for FDA Regional Field Offices and Warehouses,...
Read More
ITB No. 2022-0250-FROO-EPA || Procurement of One (1) Year Security Services for FDA Regional Field Offices and Warehouses, Cebu Testing and Quality Assurance Laboratory (CTQAL), and Davao Testing Quality Assurance Laboratory (DTQAL)

NP-SVP(A)-2022-0255-RFO-NCR || Procurement of Tires for Toyota Innova (SKW-586) and Toyota Grandia (SKW-291)

By Administrator 2  / December 19, 2022
Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of Tires for Toyota Innova (SKW-586) and Toyota Grandia (SKW-291)      ...
Read More
NP-SVP(A)-2022-0255-RFO-NCR || Procurement of Tires for Toyota Innova (SKW-586) and Toyota Grandia (SKW-291)

NP-SHPG(A)-2022-0251-ICTMD || Procurement for the ICT Equipment

By Administrator 3  / December 19, 2022
Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement for the ICT Equipment    
Read More
NP-SHPG(A)-2022-0251-ICTMD || Procurement for the ICT Equipment

NP-SVP(A)-2022-0242-ATQAL || Procurement for the Various Souvenir items for the Celebration of the 2022 National Counterfeit Week Against Counterfeit Medicines

By Administrator 3  / December 13, 2022
Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement for the Various Souvenir items for the Celebration of the 2022 National Counterfeit...
Read More
NP-SVP(A)-2022-0242-ATQAL || Procurement for the Various Souvenir items for the Celebration of the 2022 National Counterfeit Week Against Counterfeit Medicines
View More

Latest Issuances

Quick Menus

GMP

FDA ACADEMY

DOWNLOADABLES

CAREERS

FAQs

CONTACT US

Recent Posts
Quick Links
Contact Information
Address:

Civic Drive Filinvest Corporate City

Alabang, Muntinlupa City
Tel. no: (02) 8857-1900 local 1000
 
 
 
Landline: 

(02) 8857-1900
local 1000
(02) 8842-5635


Email: [email protected]

Copyright © 2023. All Rights Reserved.

Shares